[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552044":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":24,"studyPopulation":17,"armGroups":25,"interventions":32,"overallOfficials":39,"centralContacts":44,"locations":51,"responsibleParty":68,"collaborators":17,"id":71,"slug":17,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":72,"sex":78,"minAge":79,"maxAge":17,"enrollmentInfo":80,"targetDuration":17,"studyType":83,"phases":84,"briefSummary":85,"conditions":86,"keywords":17,"overallStatus":54,"whyStopped":17,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Central Hospital, Nancy, France","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":17},[9],{"measure":10,"description":11,"timeFrame":12},"Relationship between the captation of radiotracer and the cardiovascular disease","Measurement of myocardial activity","1 day",[14],{"measure":15,"description":16,"timeFrame":12},"Relationship between the captation of radiotracer and the troponin value","Correlation between the myocardial activity and the troponin value",null,{"allocation":19,"interventionModel":20,"interventionModelDescription":17,"primaryPurpose":21,"observationalModel":17,"timePerspective":17,"maskingInfo":22},"NA","SINGLE_GROUP","DIAGNOSTIC",{"masking":23,"maskingDescription":17,"whoMasked":17},"NONE","People with the selection criteria for the study, coming to the nuclear medicine department in order to benefit from a Gallium-68-DOTATOC PET\u002FCT exam as part of a diagnostic or pre-therapeutic assessment of a neuroendocrine tumor will be offer to participate in the study After sign consent, patients were install in a room to have blood drawn for Troponin Ic, BNP and CRP and after Gallium-68-DOTATOC infusion Gallium-68-DOTATOC PET\u002FCT will be recorded and immediately the cardiac record in Gated mode",[26],{"label":27,"type":28,"description":29,"interventionNames":30},"Patients","EXPERIMENTAL","Person for whom a 68Ga-DOTATOC PET\u002FCT exam is requested as part of the diagnostic or pre-therapeutic assessment of a neuroendocrine tumor",[31],"Other: Cardiac ECG-gated PET imaging will added",[33],{"type":6,"name":34,"description":35,"armGroupLabels":36,"otherNames":37},"Cardiac ECG-gated PET imaging will added","Blood sample will be used to measure troponin, BNP and CRP . After 68Ga-DOTATOC PET\u002FCT whole body recording, a cardiac ECG-gated PET imaging will added",[27],[38],"blood sample",[40],{"name":41,"affiliation":42,"role":43},"Mathieu PERRIN, MD","CHRU Nancy","PRINCIPAL_INVESTIGATOR",[45],{"name":46,"role":47,"phone":48,"phoneExt":49,"email":50},"VERONIQUE ROCH, MSc","CONTACT","03 83 15 42 76","+33","v.roch@chru-nancy.fr",[52],{"facility":53,"status":54,"city":55,"state":17,"zip":56,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"Veronique Roch","RECRUITING","Vandœuvre-lès-Nancy","54511","France","FR",{"type":60,"coordinates":61},"Point",[62,63],6.17114,48.66115,{"lat":63,"lon":62},[66],{"name":67,"role":47,"phone":17,"phoneExt":17,"email":50},"VERONIQUE ROCH",{"type":43,"investigatorFullName":69,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"Mathieu PERRIN","MD","100552044",false,"NCT06467968","Heart Analysis in GATED-PET in Patients Having a Gallium-68-DOTATOC PET\u002FCT Exam for Oncology Indication","GATED-PET Heart Analysis in Patients Having a Gallium-68--DOTATOC PET\u002FCT Exam for Oncology Indication","GATEDOTA","Inclusion Criteria:\n\nPersons who have received complete information on the organization of the research and who have signed the informed consent and:\n\n* Age ≥ 18 years old.\n* Having read and understood the information document.\n* Affiliated to a social security scheme.\n\nPerson for whom a 68Ga-DOTATOC PET\u002FCT exam is requested as part of the diagnostic or pre-therapeutic assessment of a neuroendocrine tumour.\n\nExclusion Criteria:\n\nPerson with\n\n* Hypersensitivity during previous use of 68Ga-DOTATOC\n* Impossibility of performing a PET-CT (patient agitated, confused, etc.).\n* History of heart disease,\n* Severe arrhythmia that does not allow the PET synchronized with the ECG\n* Severe renal insufficiency (GFR \\\u003C30 ml\u002Fmin\u002F1.73 m2)\n* Treated with a somatostatin analogue.\n* Cushing's syndrome\n* Pregnant woman, likely to be or breastfeeding\n* Adult subject to a legal protection measure (guardianship, curators, legal safeguard)\n* Person of legal age unable to express their consent\n* Person deprived of liberty by a judicial or administrative decision\n* Person, subject to psychiatric care under articles L. 3212-1 and L. 3213-1","ALL","18 Years",{"count":81,"type":82},99,"ESTIMATED","INTERVENTIONAL",[19],"Gallium-68-DOTATOC binds primarily with high affinity to somatostatin subtype 2 (SSTR2) receptors and these somatostatin receptors are also overexpressed on inflammation cells when activated.\n\nThe hypothesis is that the GATED mode on a Gallium-68-DOTATOC cardiac recording would be able to highlight abnormalities that could be correlated with the age of the patients and their cardiovascular risk factors.",[87],"Cardiac Inflammation","2026-06-23",{"date":90,"type":91},"2026-06-25","ACTUAL",{"date":93,"type":91},"2023-02-02",{"date":95,"type":82},"2027-05-26",{"name":5,"class":6},1]